[breadcrumb_custom]

TNXP’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect?

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price decrease of -8.19%. However, over the past six months, we’ve seen a stronger performance of -61.75%. The price of TNXP fallen by 31.21% over the last 30 days. And in the last five days, it has surged by 14.84%.

The stock market performance of Tonix Pharmaceuticals Holding Corp has been fairly unsteady. Over the last year, the company’s stock hit its highest at $6.81 on 02/16/23, while the lowest price during the same time frame was $0.26, recorded on 01/19/24.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

52-week price history of TNXP Stock

The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Tonix Pharmaceuticals Holding Corp’s current trading price is -94.57% away from its 52-week high, while its distance from the 52-week low is 42.31%. The stock’s price range for this period has been between $0.26 and $6.81. The Healthcare sector company’s shares saw a trading volume of about 3.19 million for the day, which was higher than the average daily volume of 1.95 over the last three months.

The Connection Between Financial Performance and Market Capitalization

Tonix Pharmaceuticals Holding Corp (TNXP) has experienced a quarterly decline of -21.28% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 29.90M.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.4712, with a change in price of -0.4840. Similarly, Tonix Pharmaceuticals Holding Corp recorded 1,174,178 in trading volume during the last 100 days, posting a change of -56.67%.

TNXP’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for TNXP stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.

TNXP Stock Stochastic Average

As of today, the raw stochastic average of Tonix Pharmaceuticals Holding Corp over the past 50 days is 25.47%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 87.72%. Additionally, the Stochastic %K and %D values for the company were 78.33% and 74.80%, respectively, over the past 20 days.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts